Yarbrough Capital, LLC

SEC CIK: 0001767686
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by Yarbrough Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overview All 13F holders of DNA Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of DNA by Yarbrough Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−51,100−100.0%	Sold out	Holders
Q1 2022	51,100	$206.0K	<0.1%	00.0%	Unchanged	Holders
Q4 2021	51,100	$425.0K	<0.1%	–	No prior filing	Holders